Blog

Jul 21, 2024, 10:33

Filippo Montemurro: RWE of drug-drug interactions on abemaciclib

Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X:

“Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study | NPJ Breast Cancer
Very nice paper on the impact of concomitant drugs in pts treated with abemaciclib using the DRUG-PIN tool.

Authors: Simone Scagnoli, Simona Pisegna, Angela Toss, Roberta Caputo, Michelino De Laurentiis, Michela Palleschi, Ugo de Giorgi, Enrico Cortesi, Agnese Fabbri, Alessandra Fabi, Ida Paris, Armando Orlandi, Giuseppe Curigliano, Carmen Criscitiello, Ornella Garrone, Gianluca Tomasello, Giuliana D’Auria, Patrizia Vici, Enrico Ricevuto, Federica Domati, Claudia Piombino, Sara Parola, Roberta Scafetta, Alessio Cirillo, Beatrice Taurelli Salimbeni, Francesca Sofia Di Lisa, Lidia Strigari, Robert Preissner, Maurizio Simmaco, Daniele Santini, Paolo Marchetti, Andrea Botticelli. ”

Source: Filippo Montemurro/X

Agnese Fabbri Alessandra Fabi Alessio Cirillo Andrea Botticelli Angela Toss Armando Orlandi Beatrice Taurelli Salimbeni cancer carmen criscitiello Claudia Piombino Daniele Santini Enrico Cortesi Enrico Ricevuto Federica Domati Filippo Montemurro Francesca Sofia Di Lisa Gianluca Tomasello Giuliana D'Auria Giuseppe Curigliano Ida Paris Lidia Strigari Maurizio Simmaco Michela Palleschi Michelino De Laurentiis OncoDaily Oncology Ornella Garrone Paolo Marchetti Patrizia Vici Robert Preissner Roberta Caputo Roberta Scafetta Sara Parola Simona Pisegna Simone Scagnoli Ugo de Giorgi

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC